BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 7443486)

  • 1. [Familial pyridoxine-responsive sideroblastic anaemia. One case (author's transl)].
    Garbarz M; Bernard JF; Boivin P
    Nouv Presse Med; 1980 Nov; 9(44):3345-7. PubMed ID: 7443486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An infant case of sideroblastic anemia that responded to oral pyridoxine].
    Kudo K; Ito M; Horibe K; Iwase K; Kojima S
    Rinsho Ketsueki; 1999 Aug; 40(8):667-72. PubMed ID: 10496043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin B6 responsive sideroblastic anaemia in a patient with tuberculosis.
    Demiroglu H; Dündar S
    Br J Clin Pract; 1997; 51(1):51-2. PubMed ID: 9158274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia.
    May A; Bishop DF
    Haematologica; 1998 Jan; 83(1):56-70. PubMed ID: 9542324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the understanding of inherited sideroblastic anaemia.
    Camaschella C
    Br J Haematol; 2008 Oct; 143(1):27-38. PubMed ID: 18637800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
    Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
    Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
    Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
    N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haema synthesis during pyridoxine therapy in two families with different types of hereditary sideroblastic anaemia.
    Pasanen AV; Salmi M; Tenhunen R; Vuopio P
    Ann Clin Res; 1982 Apr; 14(2):61-5. PubMed ID: 7149613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts.
    Baumann Kreuziger LM; Wolanskyj AP; Hanson CA; Steensma DP
    Eur J Haematol; 2011 Jun; 86(6):512-6. PubMed ID: 21388451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome.
    Kardos G; Veerman AJ; de Waal FC; van Oudheusden LJ; Slater R
    Med Pediatr Oncol; 1996 Jan; 26(1):54-6. PubMed ID: 7494512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sideroblastic anaemia. A review of seven paediatric cases.
    Hamel BC; Schretlen ED
    Eur J Pediatr; 1982 Mar; 138(2):130-5. PubMed ID: 7094932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haem synthesis in sideroblastic anaemia.
    Konopka L; Hoffbrand AV
    Br J Haematol; 1979 May; 42(1):73-83. PubMed ID: 465361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [X-linked sideroblastic anemia].
    Muramatsu M; Usuki K; Izutsu K; Yamaguchi Y; Iki S; Furuyama K; Kondo M; Urabe A
    Rinsho Ketsueki; 1999 Jul; 40(7):593-8. PubMed ID: 10483144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary sideroblastic anemia: a rare diagnosis].
    Brahem-Jmili N; Salem N; Abdelkefi S; Champ BG; Bekri S; Sboui H; Mahjoub T; Yacoub S; Kortas M
    Ann Biol Clin (Paris); 2004; 62(3):349-52. PubMed ID: 15217771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mechanisms for hereditary sideroblastic anemia.
    Furuyama K; Sassa S
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):5-10. PubMed ID: 11929048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired hypochromic and microcytic sideroblastic anaemia responsive to pyridoxine with low value of free erythrocyte protoporphyrin: a possible subgroup of idiopathic acquired sideroblastic anaemia (IASA).
    Takeda Y; Sawada H; Sawai H; Toi-Matsuda T; Tashima M; Okuma M; Watanabe S; Ohmori S; Kondo M
    Br J Haematol; 1995 May; 90(1):207-9. PubMed ID: 7786786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous occurrence of dyserythropoietic anaemia pyridoxine responsive and Paget's disease of bone (author's transl)].
    Bombara R; Pagliano FM; Rossi F; Santi G; Visca U
    Haematologica; 1977 Aug; 62(4):435-9. PubMed ID: 409650
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitamin B6-sensitive hereditary sideroblastic anemia].
    Heller T; Höchstetter V; Basler M; Borck V
    Dtsch Med Wochenschr; 2004 Jan; 129(4):141-4. PubMed ID: 14724775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
    Cazzola M; Malcovati L
    Hematology Am Soc Hematol Educ Program; 2015; 2015():19-25. PubMed ID: 26637696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.